AH, A., RE, P., C, R., & B, C. (2021). Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply. Alimentary pharmacology & therapeutics, 53(6), 766. https://doi.org/10.1111/apt.16287
Chicago Style (17th ed.) CitationAH, Al-Ani, Prentice RE, Rentsch C, and Christensen B. "Letter: SARS-CoV-2 Infection in Two Inflammatory Bowel Disease Patients Treated with Dual Targeted Therapy-Authors' Reply." Alimentary Pharmacology & Therapeutics 53, no. 6 (2021): 766. https://doi.org/10.1111/apt.16287.
MLA (9th ed.) CitationAH, Al-Ani, et al. "Letter: SARS-CoV-2 Infection in Two Inflammatory Bowel Disease Patients Treated with Dual Targeted Therapy-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 53, no. 6, 2021, p. 766, https://doi.org/10.1111/apt.16287.